ArticleJournal for immunotherapy of cancer2023

Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study.

Roberto Moretto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.